Protective role of urinary trypsin inhibitor in lung expression of proinflammatory cytokines accompanied by lethal liver injury in mice

References

• Sato, H., Kajikawa, S., Kuroda, S., Horisawa, Y., Nakamura, N., Kaga, N., Kakinuma, C., Kato, K., Morishita, H., Niwa, H., Miyazaki, J. Impaired fertility in female mice lacking urinary trypsin inhibitor. Biochem. Biophys. Res. Commun. 2001, 281,1154–1160.
   PubMed Web of Science ®Google Scholar
• Sumi, H., Takada, Y., Takada, A. Studies on human urinary trypsin inhibitor. 1. Its modification on treatment of urine with acid. Thromb. Res. 1977, 11,747–754.
   PubMedGoogle Scholar
• Wachter, E., Hochstrasser, K. [Kunitz-type proteinase inhibitors derived by limited proteolysis of the inter-alpha-trypsin inhibitor, IV. The amino acid sequence of the human urinary trypsin inhibitor isolated by affinity chromatography]. Hoppe Seylers Z Physiol. Chem. 1981, 362,1351–1355.
   PubMedGoogle Scholar
• Masuda, T., Sato, K.,Noda, C.,Ikeda, K.M.,Matsunaga, A.,Ogura, M. N., Shimizu, K., Nagasawa, H., Matsuyama, N., Izumi, T. Protective effect of urinary trypsin inhibitor on myocardial mitochondria during hemorrhagic shock and reperfusion. Crit. Care. Med. 2003, 31,1987–1992.
   PubMed Web of Science ®Google Scholar
• Zaitsu, M., Hamasaki, Y., Tashiro, K., Matsuo, M., Ichimaru, T., Fujita, I., Tasaki, H., Miyazaki, S. Ulinastatin, an elastase inhibitor, inhibits the increased mRNA expression of prostaglandin H2 synthase-type 2 in Kawasaki disease. J. Infect. Dis. 2000, 181,1101–1109.
   PubMed Web of Science ®Google Scholar
• Aibiki, M., Cook, J. A. Ulinastatin, a human trypsin inhibitor, inhibits endotoxin-induced thromboxane B2 production in human monocytes. Crit. Care Med. 1997, 25,430–434.
   PubMed Web of Science ®Google Scholar
• Nakamura, H., Abe, S., Shibata, Y., Sata, M., Kato, S., Saito, H., Hino, T., Takahashi, H.,Tomoike, H. Inhibition of neutrophil elastase-induced interleukin-8 gene expression by urinary trypsin inhibitor in human bronchial epithelial cells. Int. Arch. Allergy Immunol. 1997, 112,157–162.
   PubMed Web of Science ®Google Scholar
• Molor-Erdene, P., Okajima, K., Isobe, H., Uchiba, M., Harada, N., Shimozawa, N., Okabe, H. Inhibition of lipopolysaccharide-induced tissue factor expression in monocytes by urinary trypsin inhibitor in vitro and in vivo. Thromb. Haemost. 2005, 94,136–145.
   PubMed Web of Science ®Google Scholar
• Yano, T., Anraku, S., Nakayama, R., Ushijima, K. Neuroprotective effect of urinary trypsin inhibitor against focal cerebral ischemia-reperfusion injury in rats. Anesthesiology. 2003, 98,465–473.
   PubMed Web of Science ®Google Scholar
• Tani, T., Aoki, H., Yoshioka, T., Lin, K. J., Kodama, M. Treatment of septic shock with a protease inhibitor in a canine model: A prospective, randomized, controlled trial. Crit. Care Med. 1993, 21,925–930.
   PubMed Web of Science ®Google Scholar
• Molor-Erdene, P., Okajima, K., Isobe, H., Uchiba, M., Harada, N., Okabe, H. Urinary trypsin inhibitor reduces LPS-induced hypotension by suppressing tumor necrosis factor-alpha production through inhibition of Egr-1 expression. Am. J. Physiol. Heart Circ. Physiol. 2005, 288,H1265–1271.
   PubMed Web of Science ®Google Scholar
• Inoue, K., Takano, H., Shimada, A., Yanagisawa, R., Sakurai, M., Yoshino, S., Sato, H., Yoshikawa, T. Urinary trypsin inhibitor protects against systemic inflammation induced by lipopolysaccharide. Mol. Pharmacol. 2005, 67,673–680.
   PubMed Web of Science ®Google Scholar
• Inoue, K., Takano, H., Yanagisawa, R., Sakurai, M., Shimada, A., Sato, H., Kato, Y., Yoshikawa, T. Antioxidative role of urinary trypsin inhibitor in acute lung injury induced by lipopolysaccharide. Int. J. Mol. Med. 2005, 16,1029–1033.
   PubMed Web of Science ®Google Scholar
• Inoue, K., Takano, H., Yanagisawa, R., Sakurai, M.,Shimada, A., Yoshino, S., Sato, H., Yoshikawa, T. Protective role of urinary trypsin inhibitor in acute lung injury induced by lipopolysaccharide. Exp. Biol. Med. (Millwood) 2005,230,281–287.
   Google Scholar
• Takano, H., Inoue, K., Shimada, A., Sato, H., Yanagisawa, R., Yoshikawa, T. Urinary trypsin inhibitor protects against liver injury and coagulatory disturbances induced by lipopolysaccharide/D-galactosamine in mice. Lab. Invest. (In Press).
   Google Scholar
• Diaz-Buxo, J. A., Blumenthal, S., Hayes, D., Gores, P., Gordon, B.Galactosamine-induced fulminant hepatic necrosis in unanesthetized canines. Hepatology. 1997, 25,950–957.
   Google Scholar
• Kerr, R., Newsome, P., Germain, L., Thomson, E., Dawson, P., Stirling, D., Ludlam, C. A. Effects of acute liver injury on blood coagulation. J. Thromb. Haemost. 2003, 1,754–759.
   PubMed Web of Science ®Google Scholar
• Baudouin, S. V., Howdle, P., O’Grady, J. G., Webster, N. R. Acute lung injury in fulminant hepatic failure following paracetamol poisoning. Thorax. 1995, 50,399–402.
   PubMed Web of Science ®Google Scholar
• Matuschak, G. M., Pinsky, M. R., Klein, E. C., Van Thiel, D.H., Rinaldo, J. E. Effects of D-galactosamine-induced acute liver injury on mortality and pulmonary responses to Escherichia coli lipopolysaccharide. Modulation by arachidonic acid metabolites. Am. Rev. Respir. Dis. 1990, 141,1296–1306.
   Google Scholar
• Maehara, K., Kanayama, N., Halim, A., el Maradny, E., Oda, T., Fujita, M., Terao, T. Down-regulation of interleukin-8 gene expression in HL60 cell line by human Kunitz-type trypsin inhibitor. Biochem. Biophys. Res. Commun. 1995, 206,927–934.
   PubMed Web of Science ®Google Scholar
• Aosasa, S., Ono, S., Mochizuki, H., Tsujimoto, C., Ueno, C., Matsumoto, A. Mechanism of the inhibitory effect of protease inhibitor on tumor necrosis factor alpha production of monocytes. Shock. 2001, 15,101–105.
   PubMed Web of Science ®Google Scholar
• Sauer, A., Hartung, T., Aigner, J., Wendel, A. Endotoxin-inducible granulocyte-mediated hepatocytotoxicity requires adhesion and serine protease release. J Leukoc Biol 1996, 60,633–643.
   Google Scholar
• Chen, G. H., RReddy, R. C., Newstead, M. W., Tateda, K., Kyasapura, B. L., Standiford, T. J. Intrapulmonary TNF gene therapy reverses sepsis-induced suppression of lung antibacterial host defense. J. Immunol. 2000, 165,6496–6503.
   Google Scholar
• Torre, D., Minoja, G., Maraggia, D., Chiaranda, M., Tambini, R., Speranza, F., Giola, M. Effect of recombinant IL-1 beta and recombinant gamma interferon on septic acute lung injury in mice. Chest. 1994, 105,1241–1245.
   Google Scholar
• Heinzel, F. P. The role of IFN-gamma in the pathology of experimental endotoxemia. J. Immunol. 1990, 45,2920–2924.
   Google Scholar
• Kobayashi, H., Suzuki, M., Tanaka, Y., Kanayama, N., Terao, T. A Kunitz-type protease inhibitor, bikunin, inhibits ovarian cancer cell invasion by blocking the calcium-dependent transforming growth factor-beta 1 signaling cascade. J. Biol. Chem. 2003, 278,7790–7799.
   Google Scholar
• Koizumi, R., Kanai, H., Maezawa, A., Kanda, T., Nojima, Y., Narusa, T. Therapeutic effects of ulinastatin on experimental crescentic glomerulonephritis in rats. Nephron. 2000, 84,347–353.
   PubMedGoogle Scholar